Physician profile
Cara E Schiessler
NPI 1184959520
$14,413.47
in general payments reported to CMS, 2019-2025
39 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,327 · 2022: $1,316 · 2023: $6,730 · 2024: $4,003 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,902 · Food and Beverage: $3,930 · Consulting Fee: $1,767 · Travel and Lodging: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,902.00 |
| Food and Beverage | $3,929.89 |
| Consulting Fee | $1,767.00 |
| Travel and Lodging | $1,171.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $9,970.67 | 2021-2024 | Urolift |
| Urogen Pharma, INC. | $562.47 | 2023-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $423.54 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $401.26 | 2021-2025 | Erleada, Akeega |
| Palette Life Sciences, INC. | $321.59 | 2022 | |
| Myovant Sciences INC. | $290.91 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $274.65 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Boston Scientific Corporation | $231.21 | 2021-2025 | Ams 700, Rezum Generator, Lithovue |
| Janssen Scientific Affairs, LLC | $165.19 | 2023 | Erleada, Balversa, Pipeline |
| Axonics, INC. | $161.13 | 2022-2023 | Axonics |
| Urovant Sciences INC | $131.23 | 2021-2022 | |
| Galvanize Therapeutics, INC | $121.52 | 2025 | Aliya System |
| Bayer Healthcare Pharmaceuticals INC. | $116.86 | 2022-2025 | |
| Accord Healthcare, INC. | $95.88 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $93.82 | 2021-2023 | Provenge |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $85.36 | 2021-2025 | Xyosted |
| Srs Medical Systems, INC. | $84.14 | 2021 | |
| Endo Pharmaceuticals INC. | $79.05 | 2022-2024 | Xiaflex, Aveed, Edex |
| Edap Technomed INC | $78.00 | 2024 | |
| Abbvie INC. | $75.97 | 2021-2025 | |
| Procept Biorobotics Corporation | $74.25 | 2024-2025 | Aquabeam System |
| 180 Medical, INC. | $69.67 | 2021-2022 | |
| Pfizer INC. | $66.93 | 2023-2025 | |
| Rochester Medical Corporation | $65.19 | 2021-2022 | |
| Astellas Pharma US INC | $62.99 | 2021-2024 | Xtandi |
| Tolmar, INC. | $56.20 | 2023-2025 | Jatenzo, Eligard |
| Blue Earth Diagnostics | $33.98 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $31.12 | 2024-2025 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $30.61 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.15 | 2022-2023 | Lynparza |
| Verity Pharmaceuticals INC. | $17.58 | 2023 | Trelstar |
| Progenics Pharmaceuticals, INC. | $16.61 | 2025 | |
| Olympus America INC. | $15.75 | 2023 | Itind System |
| Amgen INC. | $14.64 | 2022 | |
| Endo USA, INC. | $14.24 | 2025 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $13.98 | 2023 | |
| Sun Pharmaceutical Industries INC. | $13.33 | 2024 | |
| Coloplast Corp | $12.85 | 2021 | |
| Allergan, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Schiessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.